首页> 美国卫生研究院文献>BMC Cancer >Cost-utility analysis of pralatrexate for relapsed or refractory peripheral T-cell lymphoma based on a case-matched historical control study along with single arm clinical trial

【2h】

Cost-utility analysis of pralatrexate for relapsed or refractory peripheral T-cell lymphoma based on a case-matched historical control study along with single arm clinical trial

机译：基于案例匹配的历史研究的复发或难治性外周T细胞淋巴瘤预缩醛缩写的成本分析以及单臂临床试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

The online version contains supplementary material available at 10.1186/s12885-020-07629-z.

机译：在线版本包含10.1186 / S12885-020-07629-Z可用的补充材料。

著录项

期刊名称 BMC Cancer
作者
Seonyoung Park; Ah-Young Kim; Hyeonseok Cho; Deborah Baik; Hankil Lee; Sunghwa Cho; Hye-Young Kang;
展开▼
作者单位

展开▼
年(卷),期 2020(-1),-1
年度 2020
页码 -1
总页数 11
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

机译：案例匹配的对照分析;成本实用性分析;外周T细胞淋巴瘤;普拉拉特克雷特;

相似文献

外文文献
中文文献
专利

1. Pralatrexate in Chinese Patients with Relapsed or Refractory Peripheral T-cell Lymphoma: A Single-arm, Multicenter Study [J] . Hong Xiaonan, Song Yuqin, Huang Huiqiang, Targeted oncology . 2019,第2期

机译：Pralatexate在中国复发或难治性外周T细胞淋巴瘤的患者：单臂，多中心研究
2. Relapsed refractory nodal peripheral T-cell lymphoma with follicular helper T-cell phenotype was initially resistant to pralatrexate and confirmed to be unresponsive to subsequent forodesine, but responded to re-instituted pralatrexate [J] . Yasunobu Sekiguchi, Mutsumi Wakabayashi, Haruko Takizawa, Journal of clinical and experimental hematopathology : . 2020,第1期

机译：复发难治性节点外周T细胞淋巴瘤与滤泡辅助T细胞表型最初耐血浆萃取物，并证实对随后的药物无响应，但回应重新制定的甲醛克雷特
3. A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid?) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: The EXPECT trial [J] . MorschhauserF., FitoussiO., HaiounC., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2013,第13期

机译：2期，多中心，单臂，开放标签研究，用于评估单药来那度胺（Revlimid？）在复发性或难治性外周T细胞非霍奇金淋巴瘤患者中的安全性和有效性：EXPECT试验
4. Supporting a Knowledge Base With Evidence Retrieved From Randomized Controlled Clinical Trials - A Case Study [C] . Marly G. F. COSTA, Gisele R. VIEIRA, Cicero F. F. COSTA FILHO World Multi-Conference on Systemics, Cybernetics and Informatics . 2009

机译：支持从随机对照临床试验中检索的证据的知识库 - 以案例研究
5. Image-Analysis with Fiji Program on Peripheral Blood Monocular Cells After Consumption of High-Fat, High Carbohydrate Meal with or Without Addition of Spices: A Single-Center Randomized, Blinded, Placebo-Controlled, 4-Arm, 24-hr Acute Crossover Study [D] . Tsai, Meng Fu. 2020

机译：用斐济单眼细胞进行斐济血液单眼细胞的图像分析，用或没有添加香料：单中心随机，盲，安慰剂控制，4臂，24小时急性交叉研究
6. Pralatrexate in Chinese Patients with Relapsed or Refractory Peripheral T-cell Lymphoma: A Single-arm Multicenter Study [O] . Xiaonan Hong, Yuqin Song, Huiqiang Huang, -1

机译：中国复发性或难治性周围性T细胞淋巴瘤患者中的普拉瑞沙特：单臂多中心研究
7. Cost-utility analysis of pralatrexate for relapsed or refractory peripheral T-cell lymphoma based on a case-matched historical control study along with single arm clinical trial [O] . Seonyoung Park, Ah-Young Kim, Hyenseok Cho, 2020

机译：基于案例匹配的历史研究的复发或难治性外周T细胞淋巴瘤预缩醛缩写的成本分析以及单臂临床试验

Cost-utility analysis of pralatrexate for relapsed or refractory peripheral T-cell lymphoma based on a case-matched historical control study along with single arm clinical trial

摘要

著录项

相似文献

相关主题

期刊订阅